Welcome to "ACR Journals on Air," the ACR's newest podcast series featuring interviews, commentary, and analysis on research from our three peer-reviewed journals. Join us each episode for engaging discussions with authors and independent experts about recently published studies, their implications for clinical care, and how they move the field of rheumatology forward. Whether it's an expert analysis of a manuscript or deep dive with an author – our goal is the same – to understand the impact of the science and bring it from the bench to the bedside
ACR Journals On Air
Claim This Podcastby American College of Rheumatology
5.0(20 reviews)
100 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
68
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality49
Social94
YouTube86
Engagement85
Podcast Overview
Welcome to "ACR Journals on Air," the ACR's newest podcast series featuring interviews, commentary, and analysis on research from our three peer-reviewed journals. Join us each episode for engaging discussions with authors and independent experts about recently published studies, their implications for clinical care, and how they move the field of rheumatology forward. Whether it's an expert analysis of a manuscript or deep dive with an author – our goal is the same – to understand the impact of the science and bring it from the bench to the bedside
Language
🇺🇲
Publishing Since
9/7/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
68
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality49
Social94
YouTube86
Engagement85
7
Excellent Areas
2
Good Performance
10
Growth Opportunities
excellent
Episode Length
37 minutes
Performing excellently!
good
Publishing Consistency
Every 14 days
Recommendations available
Unlock the full report to see detailed tips
poor
Episode Thumbnails
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for ACR Journals On Air
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
August 4, 2026
RA Inference in EHR
<p><span class="NormalTextRun SCXW194492617 BCX0">In this episode, we explore how artificial intelligence and machine learning are advancing the use of electronic health record data in rheumatology. Dr. Kat discusses the development and validation of a natural language processing–based model to infer rheumatoid arthritis disease activity from structured and unstructured clinical data, its application in studying cardiovascular outcomes, and the challenges of deploying predictive models across different health systems. The conversation also examines the future of real-world evidence generation, the practical limitations of AI in clinical research, and Dr. Kat's career journey, offering insights and advice for the next generation of physician-scientists.</span><span class= "EOP Selected SCXW194492617 BCX0" data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p>
July 21, 2026
Distilling Still Disease: Interstitial Lung Disease and Still
<p><span class="TextRun SCXW153409076 BCX0" lang="EN-US" xml:lang= "EN-US" data-contrast="none"><span class= "NormalTextRun SCXW153409076 BCX0">In this episode, Michael J. Ombrello, MD, explores how our understanding of Still's disease has evolved, from recognizing interstitial lung disease as a key manifestation to uncovering the immunologic and genetic factors that may shape disease severity. He discusses insights from a National Institutes of Health natural history study, including interferon signatures, HLA associations, drug-associated immunologic reactions, and exome sequencing, and explains what these findings could mean for future diagnosis, risk stratification, and treatment. The conversation also turns to Dr. Ombrello's own career path, the </span><span class= "NormalTextRun SCXW153409076 BCX0">personal experiences</span><span class= "NormalTextRun SCXW153409076 BCX0"> that inspire his research, and the mentors who helped shape his journey as a physician-scientist.</span></span><span class= "EOP Selected SCXW153409076 BCX0" data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span class="EOP Selected SCXW153409076 BCX0" data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> <a class="Hyperlink SCXW127177043 BCX0" href= "https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.70079" target="_blank" rel="noreferrer noopener"><span class= "TextRun Underlined SCXW127177043 BCX0" lang="EN-US" xml:lang= "EN-US" data-contrast="none"><span class= "NormalTextRun SCXW127177043 BCX0" data-ccp-charstyle= "Hyperlink">Type I Interferon Signature is Associated </span><span class= "NormalTextRun SCXW127177043 BCX0" data-ccp-charstyle= "Hyperlink">With</span><span class= "NormalTextRun SCXW127177043 BCX0" data-ccp-charstyle= "Hyperlink"> Lung Disease, Drug-Associated Immune Reactions, and Genetic Variation in Interferon-Linked Pathways in Still Disease</span></span></a><span class= "EOP Selected SCXW127177043 BCX0" data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></span></p>
July 7, 2026
GLP-1 receptor agonists in the RISE registry
<p><span class="NormalTextRun SCXW98690554 BCX0">In this episode, Nicholas P. McCormic discusses new real-world research from the RISE registry examining the use of GLP-1 receptor agonists in patients with rheumatic and musculoskeletal diseases. He explains the motivation behind the study, its design, and key findings on medication use, weight loss, and differences between semaglutide and tirzepatide, while highlighting important considerations for clinicians and patients. Nick also shares insights into the strengths and limitations of using registry data before reflecting on his journey from psychology and sociology to earning a Ph.D. focused on chronic disease management and rheumatology, offering advice for aspiring researchers and a look at his future work.</span><span class="EOP Selected SCXW98690554 BCX0" data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p>
100 total episodes available
Similar Podcasts
Discover related shows you might enjoy
ACR on Air
American College of Rheumatology
Rheumnow Podcast
Dr. Cush
The Evidence Based Rheumatology Podcast
Michael Putman
Healio Rheuminations
Adam J. Brown, MD
Talking Rheumatology Spotlight
British Society for Rheumatology
Rheumatology For The Royal College
Dr. Karim Ladak
Around the Rheum
Canadian Rheumatology Association
The Lancet Rheumatology in conversation with
The Lancet Group
Annals On Call Podcast
American College of Physicians
JAMA Editors' Summary
JAMA Network
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
Mayo Clinic Talks
Mayo Clinic
The Curious Clinicians
The Curious Clinicians
NEJM This Week
NEJM Group
AFP: American Family Physician Podcast
American Academy of Family Physicians
Deep-dive analytics for ACR Journals On Air
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is ACR Journals On Air?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.